EarningsQ4 2020 Earnings Report

Relmada Therapeutics (4E2) Q4 2020 Earnings Report

0 Followers

DE:4E2 Q4 2020 EPS Results

Actual EPS-€1.14

Consensus EPS―

Beat/Miss―

One Year Ago EPS―

Actual Revenue€0.00

Expected Revenue―

Beat/Miss―

YoY Revenue Growth―

QuarterQ4 2020

Date03/23/2021

TimeAfter Close

Conference CallTuesday, March 23, 2021

DE:4E2 Upcoming Earnings

Relmada Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-0.13 / -	-0.267	―
Aug 06, 2026	2026 (Q2)	-0.18 / -0.10	-0.267	63.33% (+0.17)
May 12, 2026	2026 (Q1)	-0.18 / -0.20	-0.516	62.07% (+0.32)
Mar 19, 2026	2025 (Q4)	-0.13 / -0.24	-0.552	56.45% (+0.31)
Nov 13, 2025	2025 (Q3)	-0.38 / -0.27	-0.641	58.33% (+0.37)
Aug 07, 2025	2025 (Q2)	-0.41 / -0.27	-0.525	49.15% (+0.26)
May 12, 2025	2025 (Q1)	-0.43 / -0.52	-0.641	19.44% (+0.12)
Mar 27, 2025	2024 (Q4)	-0.60 / -0.55	-0.747	26.19% (+0.20)
Nov 07, 2024	2024 (Q3)	-0.60 / -0.64	-0.65	1.37% (<+0.01)
Aug 07, 2024	2024 (Q2)	-0.74 / -0.52	-0.747	29.76% (+0.22)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed